Mrs Ashley Marie Fugate, FNP-BC in Battle Creek, MI - Medicare

Mrs Ashley Marie Fugate, FNP-BC is a medicare enrolled "Nurse Practitioner - Family" physician in Battle Creek, Michigan. Her current practice location is 181 Emmett St W, Battle Creek, Michigan. You can reach out to her office (for appointments etc.) via phone at (269) 965-8866.

Mrs Ashley Marie Fugate is licensed to practice in Michigan (license number 4704268183) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1104281583.

Contact Information

	Mrs Ashley Marie Fugate, FNP-BC
	181 Emmett St W, Battle Creek, MI 49037-2963
	(269) 965-8866
	Not Available

Physician's Profile

Full Name	Mrs Ashley Marie Fugate
Gender	Female
Speciality
Experience	Years
Location	181 Emmett St W, Battle Creek, Michigan
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mrs Ashley Marie Fugate attended and graduated from in

NPI Data:

NPI Number: 1104281583
Provider Enumeration Date: 12/29/2015
Last Update Date: 11/01/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Mrs Ashley Marie Fugate such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104281583	NPI	-	NPPES
201368160	Medicaid	IN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	28181495A (Indiana)	Secondary
363L00000X	Nurse Practitioner	71006097A (Indiana)	Secondary
363LA2200X	Nurse Practitioner - Adult Health	71006097A (Indiana)	Secondary
363LF0000X	Nurse Practitioner - Family	71006097A (Indiana)	Secondary
363LF0000X	Nurse Practitioner - Family	4704268183 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Ashley Marie Fugate is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Ashley Marie Fugate, FNP-BC 181 Emmett St W, Battle Creek, MI 49037-2963 Ph: (269) 966-2600	Mrs Ashley Marie Fugate, FNP-BC 181 Emmett St W, Battle Creek, MI 49037-2963 Ph: (269) 965-8866

News Archive

Lack of awareness among referring physicians limits intervention in venous system: MRG

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system.

Intellect Neurosciences receives Notice of Allowance for new OXIGON patent in Canada

Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.

Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy

Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy and can be offered as a treatment option, according to the American Academy of Neurology and the Child Neurology Society in a new practice guideline published in the January 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

Understanding of tumor biology opens new opportunities to conduct clinical trial for thoracic tumors

Our understanding of tumor biology has improved and continues to expand at a rapid pace, and this has opened new opportunities for cancer clinical trials, particularly for thoracic tumors. The identification and molecular alterations in the cancer and the possibility to specifically and selectively target them, has dramatically improved the treatment efficacy in patients with lung cancer.

Mrs Ashley Marie Fugate, FNP-BC - Medicare in Battle Creek, MI